Article info

other Versions

Download PDFPDF

Can somatic BRCA2 status solve a case of olaparib monotherapy resistance?

Authors

  1. Correspondence to Anna Fagotti, Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome 00168, Italy; annafagotti70{at}gmail.com

Citation

Pietragalla A, Minucci A, Marchetti C, et al
Can somatic BRCA2 status solve a case of olaparib monotherapy resistance?

Publication history

  • Accepted August 23, 2019
  • First published September 19, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.